Doxorubicin-Induced Cardiomyopathy

This publication has 150 references indexed in Scilit:

• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
  Biochemical Pharmacology, 1999
• Doxorubicin‐induced cardiomyopathy treated with carvedilol
  Clinical Cardiology, 1998
• Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients
  American Heart Journal, 1995
• Formation, resealing and persistence of DNA breaks produced by 4-demethoxydaunorubicin in P388 leukemia cells
  Chemico-Biological Interactions, 1989
• Heart Transplantation in a Child with Doxorubicin-Induced Cardiomyopathy
  New England Journal of Medicine, 1988
• Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer
  New England Journal of Medicine, 1988
• Direct detection of paramagnetic species in adriamycin perfused rat hearts
  Biochemical and Biophysical Research Communications, 1988
• Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy
  The American Journal of Medicine, 1987
• Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA
  Chemico-Biological Interactions, 1979
• Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography
  New England Journal of Medicine, 1979